Quality documentation since 2019

Peptide information and GLP-1 knowledge – clear, independent and traceable.

PeptideLabs explains peptides, mechanisms, research status, GLP-1, quality control and laboratory testing clearly in one place.

profiles
64
blends
9
languages
5

Ask PeptideLabs · no AI cost

What would you like to understand?

Ask a short question or name a substance. This guide searches the existing PeptideLabs content in your browser and takes you to the relevant detailed page.

No AI API · no quota · nothing is sent or stored

Open peptide atlas
Open peptide atlas

Accessories

Pens, syringes & storage

Browse products, choose a pack and enquire by email.

All accessories

Publisher & review path

Who publishes—and how content is checked.

Thomas Thome carries editorial responsibility. A defined process sits behind it: clarify status, separate evidence levels, link sources and document changes openly.

Publisher & responsible editor: Thomas Thome

How source material becomes a profile

What matters is not the number of sources, but which question a source can genuinely answer.

  1. 01Clarify statusCheck agency documents and study registers first.
  2. 02Separate evidenceDo not mix human, preclinical and community claims.
  3. 03Document the stateKeep dates, primary sources and open evidence gaps visible.

This identifies editorial and legal responsibility. No medical or pharmaceutical qualification is claimed.

Research Pulse

What changed on PeptideLabs

New context, revised profiles and visible data dates turn the atlas into a living reference.

Current editorial updates
Editorial responsibility according to the legal notice: Thomas ThomeAll changes and methodology
Background and deeper readingOpen additional explanations, methods and frequently asked questions.

How to read PeptideLabs

More information, with the layers kept distinct.

Every page combines four layers that are often blurred together. This makes clear what is established, what is still being studied and where evidence is missing.

Editorial still life with an abstract molecular model, glass planes and an analytical paper sample
Editorial visualisation · not a structural formula

Name & classification

Aliases, substance class and mechanism help orientation, but are not evidence of effectiveness.

Status & context

Approval, indication, region and development stage are considered separately rather than collapsed into one label.

Evidence & method

Study type, measurement method and source determine how much weight a statement can carry.

Limits & gaps

Missing human, long-term or quality data remain visible instead of being replaced by certainty.

Peptide Atlas

An atlas for GLP-1, research peptides and their biological signals.

Short profiles covering active class, mechanism, research focus and regulatory status — without peptide sales or use instructions.

Open the peptide atlas64 Profiles · 11 Research areas
Ordered archival cards, glass planes and an abstract molecular model representing the peptide atlas
Atlas visualisation · model is not substance-specific